“This vaccine is authorized for emergency use in individuals aged 18 years and older. This is a two-dose vaccine, given one month apart. Clinical trial data shows the vaccine is about 94% effective after two doses. No serious safety concerns were found. We expect to get our first shipment of the vaccine the week of December 21st.”
-Washington State Department of Health